Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD

Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels.

Annals of Internal Medicine · 1974 · 1.5K citations

Medicine, Cardiology, Physiology +17

Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)

Roland Buhl, François Maltais, R Abrahams et al. · European Respiratory Journal · 2015 · 322 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta‐adrenoceptor agonists and theophylline.

R.G. Goldie, Domenico Spina, KM Lulich et al. · British Journal of Clinical Pharmacology · 1986 · 264 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +6

Efficacy and safety of NVA237 <i>versus</i> placebo and tiotropium in patients with COPD: the GLOW2 study

Edward Kerwin, Jacques Hébert, Nicola Gallagher et al. · European Respiratory Journal · 2012 · 209 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study

Paul Jones, Dave Singh, Eric Bateman et al. · European Respiratory Journal · 2012 · 184 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17